Quantify

Moderna, Inc. vs Pfizer, Inc. — Stock Comparison

Moderna, Inc. (MRNA) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

vs
Q·Score Winner
Pfizer, Inc.
PFE6.2/10vs 4.8/10

Pfizer, Inc. scores ahead of Moderna, Inc. on Q·Score (6.2 vs 4.8 out of 10), led by Quality (6.4 vs 0.6) and Valuation (7 vs 3). Moderna, Inc. scores higher on Growth, reflecting stronger revenue and earnings momentum. Analyst consensus targets imply greater upside for PFE (+11.4%) than for MRNA (-13.2%).

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
● MRNA● PFE

Q·Score Breakdown

4.8
Bearish
Overall
6.2
Neutral
0.6
Quality
6.4
9.4
Health
7
8.3
Growth
5.1
3
Valuation
7
3.7
Sentiment
5.3
MRNA

Clean balance sheet with low leverage (0.2× debt-to-equity).

⚠ currently unprofitable (-144% margin).

PFE

Consistently beats earnings estimates (4/4 quarters).

⚠ earnings contracting 10% year-over-year.

Analyst Consensus

Neutral
-13.2%
Target $43.30
20 analysts
Neutral
+11.4%
Target $29.19
27 analysts

Fundamentals

MRNA
PFE
—
Trailing P/E
20.0×
-11.9×
Forward P/E
9.3×
-143.55%
Profit Margin
11.83%
-69.89%
Gross Margin
74.80%
-36.56%
ROE
8.31%
260.20%
Revenue Growth
5.40%
—
Earnings Growth
-10.10%
1.03
Beta
0.29
—
Dividend Yield
6.56%
$19.8B
Market Cap
$149.4B
52-Week Range
MRNA
$2274% of range$60
PFE
$2355% of range$29

Frequently Asked Questions

MRNA vs PFE: which stock scores better overall?

Based on Q·Score, Pfizer, Inc. (PFE) scores 6.2/10 versus Moderna, Inc. (MRNA) at 4.8/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: MRNA or PFE?

Moderna, Inc. (MRNA) scores higher on Growth (8.3/10 vs 5.1/10). Moderna, Inc. reports revenue growth (260.2% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is MRNA or PFE more attractively valued?

Pfizer, Inc. (PFE) scores higher on Valuation (7/10 vs 3/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about MRNA vs PFE?

There are 20 analysts covering MRNA with a consensus price target of $43.30, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: MRNA or PFE?

Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 0.6/10). Net profit margin: MRNA at -143.6%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: MRNA or PFE?

Moderna, Inc. (MRNA) scores higher on Financial Health (9.4/10 vs 7/10). Market beta: MRNA at 1.03, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of MRNA and PFE?

Moderna, Inc. (MRNA) has a market capitalisation of $19.8B, while Pfizer, Inc. (PFE) has a market cap of $149.4B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do MRNA or PFE pay dividends?

MRNA does not currently pay a dividend, while PFE pays a dividend yield of 6.56%. Dividend yields fluctuate with share price and company payout decisions.

Related Comparisons

JNJ vs PFELLY vs PFEAMGN vs MRNAGILD vs MRNABNTX vs MRNA

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026